Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study

Elpis Hatziagorou, Eleana Kouroukli, Maria Galogavrou, Dafni Papanikolaou, Dr Despoina Terzi, Pinelopi Anagnostopoulou, Fotios Kirvassilis, Demosthenes B. Panagiotakos, John Tsanakas

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Background: Inhaled Corticosteroids (ICS) are the cornerstone of asthma management in pediatric patients. However, in some cases, asthma is not adequately controlled on ICS alone. Long-acting beta 2 -agonists (LABA) are one of the available additional therapies but their use has rarely been studied among children younger than 5 years. Objective: The aim of this observational study was to evaluate the efficacy and safety of the combination of fluticasone propionate and salmeterol (FP/SA) in asthmatic children younger than 5 years of age. Methods: A retrospective study of 796 children under the age of 5 years (2.87 ± 1.22 years, 64.2% males), who were treated with FP/SA was conducted. Hospitalization rates, frequency of wheezing, exercise induced asthma, nocturnal wheeze and drug-related side-effects were recorded through children's medical records. Results: The children had previously received short-acting β 2 -agonists (73%), ICS (17%), montelukast (1%), and ICS with montelukast (2%). Mean duration of therapy with FP/SA was 12.45 ± 9.14 months. After adjusting for age, gender, and duration of treatment, a 89% reduction was recorded in annual hospitalization rates (from 27.13% before treatment to 3.01% after FP/SA therapy, p < 0.001), a 71% reduction in incidence of exercise-induced asthma (36.8% vs. after 10.6%, p < 0.001), a 81% reduction in nocturnal asthma (33.7% vs. after: 6.4%, p < 0.001), as well as in frequency of wheezing (p < 0.01),. No previous treatment carry-on effect was observed. No major drug-related side-effects occurred in the study group. Conclusions: Combination therapy (FP/SA) is well-tolerated and highly effective in asthmatic children under the age of 5 years.

Original languageEnglish
Pages (from-to)573-580
Number of pages8
JournalJournal of Asthma
Volume56
Issue number6
DOIs
Publication statusPublished - 3 Jun 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study'. Together they form a unique fingerprint.

Cite this